ATE491702T1 - N-dihydroxyalkyl-substitutierte 2- oxoimidazolderivate - Google Patents

N-dihydroxyalkyl-substitutierte 2- oxoimidazolderivate

Info

Publication number: ATE491702T1
Authority: AT; Austria
Prior art keywords: agent; therapeutic agent; preventive; therapeutic; carbon atoms
Prior art date: 2005-07-13

Application number

AT06781147T

Other languages

English (en)

Inventor

Masaya Hashimoto

Yoshikazu Iwasawa

Hiroshi Kawamoto

Hisashi Ohta

Satoshi Ozaki

Takeshi Sagara

Hiroki Sakoh

Atsushi Satoh

Original Assignee

Banyu Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-07-13

Filing date

2006-07-11

Publication date

2011-01-15

2006-07-11 Application filed by Banyu Pharma Co Ltd filed Critical Banyu Pharma Co Ltd

2011-01-15 Application granted granted Critical

2011-01-15 Publication of ATE491702T1 publication Critical patent/ATE491702T1/de

Links

WZELXJBMMZFDDU-UHFFFAOYSA-N Imidazol-2-one Chemical class O=C1N=CC=N1 WZELXJBMMZFDDU-UHFFFAOYSA-N 0.000 title 1
239000003795 chemical substances by application Substances 0.000 abstract 7
239000003814 drug Substances 0.000 abstract 5
229940124597 therapeutic agent Drugs 0.000 abstract 5
230000003449 preventive effect Effects 0.000 abstract 3
125000004432 carbon atom Chemical group C* 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
239000004084 narcotic analgesic agent Substances 0.000 abstract 2
239000012313 reversal agent Substances 0.000 abstract 2
206010012289 Dementia Diseases 0.000 abstract 1
208000004880 Polyuria Diseases 0.000 abstract 1
208000007271 Substance Withdrawal Syndrome Diseases 0.000 abstract 1
206010048010 Withdrawal syndrome Diseases 0.000 abstract 1
229940124377 agent for diabetes insipidus Drugs 0.000 abstract 1
125000001931 aliphatic group Chemical group 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
230000000202 analgesic effect Effects 0.000 abstract 1
239000000883 anti-obesity agent Substances 0.000 abstract 1
239000000935 antidepressant agent Substances 0.000 abstract 1
229940125710 antiobesity agent Drugs 0.000 abstract 1
235000021407 appetite control Nutrition 0.000 abstract 1
125000002619 bicyclic group Chemical group 0.000 abstract 1
125000002837 carbocyclic group Chemical group 0.000 abstract 1
230000003920 cognitive function Effects 0.000 abstract 1
230000007423 decrease Effects 0.000 abstract 1
230000008451 emotion Effects 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
230000007087 memory ability Effects 0.000 abstract 1
230000004770 neurodegeneration Effects 0.000 abstract 1
208000015122 neurodegenerative disease Diseases 0.000 abstract 1
239000002764 nociceptin receptor antagonist Substances 0.000 abstract 1
230000001373 regressive effect Effects 0.000 abstract 1
201000000980 schizophrenia Diseases 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT06781147T 2005-07-13 2006-07-11 N-dihydroxyalkyl-substitutierte 2- oxoimidazolderivate ATE491702T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2005204264		2005-07-13
JP2006014122		2006-07-11

Publications (1)

Publication Number	Publication Date
ATE491702T1 true ATE491702T1 (de)	2011-01-15

Family

ID=40328193

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT06781147T ATE491702T1 (de)	2005-07-13	2006-07-11	N-dihydroxyalkyl-substitutierte 2- oxoimidazolderivate

Country Status (2)

Country	Link
AT (1)	ATE491702T1 (de)
MX (1)	MX2008000565A (de)

2006
- 2006-07-11 MX MX2008000565A patent/MX2008000565A/es active IP Right Grant
- 2006-07-11 AT AT06781147T patent/ATE491702T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
MX2008000565A (es)	2008-03-14

Similar Documents

Publication	Publication Date	Title
HRP20110425T1 (en)	2011-07-31	Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone
GT200400092A (es)	2005-01-11	Preparacion y uso de derivados de alquilarilo para el tratamiento de la obesidad
DE602004022404D1 (de)	2009-09-17	4-anilino-chinazolin-derivate als proliferationshemmende mittel
PE20071321A1 (es)	2007-12-29	Bencensulfonil-cromano, tiocromano, tetrahidronaftaleno e inhibidores de gamma secretasa relacionados
GT200400013A (es)	2004-12-16	Compuestos de pirazolotriazina y usos de los mismos
DE602007007614D1 (de)	2010-08-19	Substituierte pyrrolidinone als hemmer von 11-beta-hydroxysteroiddehydrogenase 1
AR064736A1 (es)	2009-04-22	Agonistas de gpcr
EP2754454A3 (de)	2014-09-24	Derivaten von nicht-Steroide entzündungshemmende Arzneimittel
AR064735A1 (es)	2009-04-22	Agonistas de gpcr y composicion farmaceutica en base al compuesto
DE602004018630D1 (en)	2009-02-05	Substituierte 3-cyanothiophen acetamide als glucagon receptor antagonisten
TW200740436A (en)	2007-11-01	N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives
GT200500292A (es)	2006-05-11	Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica
AR064198A1 (es)	2009-03-18	Piperidinilamino piridazinas como antagonistas del receptor de dopamina 2 de rapida disociacion. procesos de obtencion y composiciones farmaceuticas
ATE396995T1 (de)	2008-06-15	4-oxoimidazolidin-2-spiro piperidin derivat
ATE491702T1 (de)	2011-01-15	N-dihydroxyalkyl-substitutierte 2- oxoimidazolderivate
BRPI0911659B8 (pt)	2021-05-25	composto 3-fenilpirazolo[5,1-b]tiazol e composição farmacêutica compreendendo o mesmo
TW200740795A (en)	2007-11-01	Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
TW200628433A (en)	2006-08-16	N-substituted imides as polymerization initiators
NO20092804L (no)	2009-10-05	Kondensert, substituert aminopyrrolidinderivat
Wolkenberg et al.	2009	Discovery of GlyT1 inhibitors with improved pharmacokinetic properties
DE602005026865D1 (de)	2011-04-21	Pyrazolopyrimidinverbindungen als antitumormittel
GT200600490A (es)	2007-07-06	Derivados de isoquinolina y benzo[h]isoquinolina su preparación y su utilización en terapéutica
AR061519A1 (es)	2008-09-03	Derivados de fenilpentadienoilo y composicion farmaceutica
Lin et al.	2013	Conformation and photochemical properties of 3-benzoyl-4-benzylamino-7-dimethylaminocoumarin
CR10267A (es)	2008-11-18	Agente terapéutico o profiláctico para el síndrome de colon irritable

Legal Events

Date	Code	Title	Description
2011-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties